Mohamed Abdel-Fattah

Mr. Mohamed Abdel-Fattah

Ain Shams University, Cairo, Egypt
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2025 in Cancer Research
Verified
Journal Article
Closed access
FPFlaminia Pedretti
Flaminia Pedretti
Mohamed Abdel-FattahMohamed Abdel-Fattah
Mohamed Abdel-Fattah
BPBenedetta Pellegrino
Benedetta Pellegrino
FMFrancesca Mateo
Francesca Mateo
PSPaula Martinez Sanz
Paula Martinez Sanz
VSVioleta Serra
Violeta Serra
Homologous recombination deficiency (HRD) contributes to genomic instability and leads to sensitivity to PARP inhibitors (PARPi). HRD also activates the cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING)–interferon pathway, highlighting the need to understand the impact of cGAS–STING–IFN signaling on PARPi efficacy. In this study, we analyzed a cohort of 35 breast cancer patient-derived xenografts and mouse-derived allografts. PARPi sensitivity correlated with HRD, increased genomic instability, and activation of the cGAS–STING–IFN signaling pathway. Single-cell analyses showed that IFN signaling and IFN-based immune interactions were suppressed in preclinical models with acquired resistance to PARPi, lacking concomitant clonal expansion of functional CD8+ T cells. However, the combination of a PARPi and a novel STING agonist (STINGa) increased immune infiltration and resulted in superior antitumor activity in these tumors. Notably, the efficacy of PARPi monotherapy and the combination treatment with a STINGa was dependent on natural killer (NK) cells. In agreement, patients with breast cancer with BRCA1/BRCA2 mutations and good responses to PARPi showed higher abundancy of CD56+ NK cells in the tumor microenvironment and treatment-engaged CD56bright NK cells in the peripheral immune compartment, compared with those with poor responses. Therefore, these findings propose the combination of PARPis and a STINGa as a potential novel strategy to enhance the therapeutic response in patients with acquired PARPi resistance and highlight a pivotal role of NK cells in the PARPi antitumor activity. Significance: PARP inhibitor sensitivity is associated with cGAS–STING–IFN signaling, which can be harnessed by combining PARP inhibitors with STING agonists to overcome acquired resistance and requires NK cells to mediate antitumor immunity. See related commentary by Gohari et al., p. 1747

Verified
Journal Article
Open access
PDF file
AYAmira Salah El-Din Youssef
Amira Salah El-Din Youssef
Mohamed Abdel-FattahMohamed Abdel-Fattah
Mohamed Abdel-Fattah
MLMai Lotfy
Mai Lotfy
ANAuhood Nassar
Auhood Nassar
MAMohamed Abouelhoda
Mohamed Abouelhoda
AZAbdel Rahman N. Zekri:
Abdel Rahman N. Zekri:
This study aims at identifying common pathogenic somatic mutations at different stages of colorectal carcinogenesis in Egyptian patients. Our cohort included colonoscopic biopsies collected from 120 patients: 20 biopsies from patients with inflammatory bowel disease, 38 from colonic polyp patients, and 62 from patients with colorectal cancer. On top of this, the cohort included 20 biopsies from patients with non-specific mild to moderated colitis. Targeted DNA sequencing using a customized gene panel of 96 colorectal related genes running on the Ion Torrent NGS technology was used to process the samples. Our results revealed that 69% of all cases harbored at least one somatic mutation. Fifty-seven genes were found to carry 232 somatic non-synonymous variants. The most frequently pathogenic somatic mutations were localized in TP53, APC, KRAS, and PIK3CA. In total, 16 somatic mutations were detected in the CRC group and in either the IBD or CP group. In addition, our data showed that 51% of total somatic variants were CRC-specific variants. The average number of CRC-specific variants per sample is 2.4. The top genes carrying CRC-specific mutations are APC, TP53, PIK3CA, FBXW7, ATM, and SMAD4. It seems obvious that TP53 and APC genes were the most affected genes with somatic mutations in all groups. Of interest, 85% and 28% of the APC and TP53 deleterious somatic mutations were located in Exon 14 and Exon 3, respectively. Besides, 37% and 28% of the total somatic mutations identified in APC and TP53 were CRC-specific variants, respectively. Moreover, we identified that, in 29 somatic mutations in 21 genes, their association with CRC patients was unprecedented. Ten detected variants were likely to be novel: six in PIK3CA and four variants in FBXW7. The detected P53, Wnt/βcatenin, Angiogenesis, EGFR, TGF-β and Interleukin signaling pathways were the most altered pathways in 22%, 16%, 12%, 10%, 9% and 9% of the CRC patients, respectively. These results would contribute to a better understanding of the colorectal cancer and in introducing personalized therapies for Egyptian CRC patients.

7 January 2021 in Genes
Verified
Journal Article
Open access
PDF file
Bishoy WadieBishoy Wadie
Bishoy Wadie
Mohamed Abdel-FattahMohamed Abdel-Fattah
Mohamed Abdel-Fattah
AHAlshymaa Hassan
Alshymaa Hassan
SMShaimaa Mouftah
Shaimaa Mouftah
MEMohamed Elhadidy
Mohamed Elhadidy
Tamer SalemTamer Salem
Tamer Salem
Campylobacter spp. represents the most common cause of gastroenteritis worldwide with the potential to cause serious sequelae. The ability of Campylobacter to survive stressful environmental conditions has been directly linked with food-borne illness. Toxin-antitoxin (TA) modules play an important role as defense systems against antimicrobial agents and are considered an invaluable strategy harnessed by bacterial pathogens to survive in stressful environments. Although TA modules have been extensively studied in model organisms such as Escherichia coli K12, the TA landscape in Campylobacter remains largely unexplored. Therefore, in this study, a comprehensive in silico screen of 111 Campylobacter (90 C.jejuni and 21 C.coli) isolates recovered from different food and clinical sources was performed. We identified 10 type II TA systems belonging to four TA families predicted in Campylobacter genomes. Furthermore, there was a significant association between the clonal population structure and distribution of TA modules; more specifically, most (12/13) of the Campylobacter isolates belonging to ST-21 isolates possess HicB-HicA TA modules. Finally, we observed a high degree of shared synteny among isolates bearing certain TA systems or even coexisting pairs of TA systems. Collectively, these findings provide useful insights about the distribution of TA modules in a heterogeneous pool of Campylobacter isolates from different sources, thus developing a better understanding regarding the mechanisms by which these pathogens survive stressful environmental conditions, which will further aid in the future designing of more targeted antimicrobials.

17 June 2026
Verified
Other
Open access
FPFlaminia Pedretti
Flaminia Pedretti
Mohamed Abdel-FattahMohamed Abdel-Fattah
Mohamed Abdel-Fattah
BPBenedetta Pellegrino
Benedetta Pellegrino
FMFrancesca Mateo
Francesca Mateo
PSPaula Martinez Sanz
Paula Martinez Sanz
VSVioleta Serra
Violeta Serra
Bulk RNA sequencing of Mouse Derived Allograft (MDA) tumors.

17 June 2026
Verified
Other
Open access
FPFlaminia Pedretti
Flaminia Pedretti
Mohamed Abdel-FattahMohamed Abdel-Fattah
Mohamed Abdel-Fattah
BPBenedetta Pellegrino
Benedetta Pellegrino
FMFrancesca Mateo
Francesca Mateo
PSPaula Martinez Sanz
Paula Martinez Sanz
VSVioleta Serra
Violeta Serra
Generation of PDX230OR8 and analysis of the mechanism of PARPi resistance

17 June 2026
Verified
Other
Open access
FPFlaminia Pedretti
Flaminia Pedretti
Mohamed Abdel-FattahMohamed Abdel-Fattah
Mohamed Abdel-Fattah
BPBenedetta Pellegrino
Benedetta Pellegrino
FMFrancesca Mateo
Francesca Mateo
PSPaula Martinez Sanz
Paula Martinez Sanz
VSVioleta Serra
Violeta Serra
Image analysis of tissue cyclic immunofluorescence in HRR-altered patients